Lowell Therapeutics is developing a breakthrough product and a company that makes a real difference in the lives of critically ill patients in the ICU. The phase 3 primary endpoint for their product, Niyad, will be met by proving it anti-coagulates blood.

Pharmaceutical

Lowell Therapeutics

Lowell Therapeutics' headquarters in Lowell, MA, United States

Michelle Merrigan

Elaine Liong

Kathleen Liu

Stuart Goldstein

John Kellum

Lowell Therapeutics' Leadership Team includes James Wilkie and 2 others.

About

People (2)

Elaine Liong

Michelle Merrigan

Jobs